Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Should You Buy Hims & Hers Stock on the Dip?
09:34am, Friday, 08'th Aug 2025
The company reported quarterly financial results that underwhelmed investors in the stock market.
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc.(HIMS)
08:45am, Friday, 08'th Aug 2025
NEW YORK , Aug. 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities law
SAN DIEGO , Aug. 8, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23,
Hims & Hers: A Game-Changer in Telehealth or Just Another Fad?
07:00pm, Thursday, 07'th Aug 2025
Explore the exciting world of Hims & Hers (HIMS -0.16%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market tr
Contact The Gross Law Firm by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc. (HIMS)
04:34pm, Thursday, 07'th Aug 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:09pm, Thursday, 07'th Aug 2025
LOS ANGELES , Aug. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Healt
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims & Hers Health, Inc. ("Hims &
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Hims & Hers Redefines Virtual Care With Integrated Tech Platforms
11:56am, Thursday, 07'th Aug 2025
HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.
Hims & Hers: A High-Risk Bet
10:27am, Thursday, 07'th Aug 2025
Upgrading Hims & Hers Health, Inc. to a speculative Buy after a 20% post-earnings selloff, given management's reaffirmed guidance and near-term demand for personalized compounded GLP-1s. I believe the
HIMS LAWSUIT ALERT: The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
08:45am, Thursday, 07'th Aug 2025
NEW YORK , Aug. 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the
NEW ORLEANS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securi
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower
Hims & Hers: From Telehealth To Wellness Hub, The Bright Future
09:32pm, Wednesday, 06'th Aug 2025
I remain bullish on Hims & Hers Health, viewing the recent price dip as a buying opportunity given its strong long-term prospects. Technological innovation and personalized care, including at-home lab
Hims & Hers: Still Growing After Breakup With Novo Nordisk
01:49pm, Wednesday, 06'th Aug 2025
Hims & Hers is positioned as a leading telehealth platform targeting millennial and Gen Z consumers with affordable, accessible healthcare solutions. The company's strong revenue growth, expanding pro
